Zhengye Biotechnology Hol...

NASDAQ: ZYBT · Real-Time Price · USD
9.49
1.89 (24.87%)
At close: Aug 20, 2025, 3:59 PM
9.50
0.11%
After-hours: Aug 20, 2025, 04:49 PM EDT

Zhengye Biotechnology Income Statement

Financials in CNY. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
186.36M 211.65M 260.27M 214.07M
Cost of Revenue
95.06M 81.8M 106.75M 88.67M
Gross Profit
91.3M 129.85M 153.52M 125.39M
Operating Income
16.44M 44.99M 65.83M 52.38M
Interest Income
231K 312K 114K 112K
Pretax Income
14.39M 43.76M 63.91M 53.07M
Net Income
11.31M 31.46M 46.73M 38.96M
Selling & General & Admin
63.84M 66.63M 63.56M 58.19M
Research & Development
12.79M 11.9M 13.42M 11.37M
Other Expenses
-1.78M 6.33M 10.7M 3.45M
Operating Expenses
74.86M 84.87M 87.69M 73.01M
Interest Expense
4.04M 4.42M 2.84M 1.05M
Selling & Marketing Expenses
41.27M 40.74M 34.56M 35.9M
Cost & Expenses
169.92M 166.66M 194.44M 161.68M
Income Tax Expense
924K 6.25M 8.17M 6.6M
Shares Outstanding (Basic)
n/a n/a n/a n/a
Shares Outstanding (Diluted)
n/a n/a n/a n/a
EPS (Basic)
n/a n/a n/a n/a
EPS (Diluted)
n/a n/a n/a n/a
EBITDA
42.6M 72.1M 85.55M 70.12M
EBIT
18.44M 48.19M 66.75M 54.11M
Depreciation & Amortization
24.16M 23.91M 18.8M 16.01M